Read more
00:44 · 1 August 2024

Meta rises almost to $500 on strong financial results

Meta Platforms reported strong financial results for the second quarter of 2024, exceeding analyst expectations on both revenue and earnings per share (EPS). Key takeaways:

  • Revenue: $39.07 billion, compared to the estimate of $38.34 billion and $36.45 billion in the previous quarter
  • EPS: $5.16, compared to the estimate of $4.72, up from $4.71 in the previous quarter
  • Guidance for expenses: $37-$40 billion from a previous $35-$40 billion, compared to expectations compiled by Bloomberg of $37.6 billion (2024
  • Capex for 2025: The company says that it should even increase its capex for 2025
  • AI: Mark Zuckerberg said that Meta AI is on track to be the most popular AI assistant in the world by the end of 2024

The company's core advertising business remained strong, with ad revenue of $39.07 billion, coming in ahead of the estimate of $38.34 billion. Looking at other measure, revenue from the company's family of apps, which includes Facebook, Instagram, and WhatsApp, was also higher than expected, at $38.72 billion compared to the estimate of $37.76 billion. Operating income rose to $14.85 billion and operating margin rose to 38%. The market estimates that the family active people rose 7% to 3.27 billion, compared with estimates of 3.22 billion.

Meta's Reality Labs segment, which includes the company's virtual and augmented reality initiatives, reported revenue of $353 million, which was slightly below the estimate of $376.9 million. However, the segment's operating loss narrowed to $4.49 billion, compared to a loss of $3.8 billion in the previous quarter.

Overall, Meta's Q2 results were a positive surprise for investors, and the company's stock price rose in after-hours trading by nearly 5% to $500 per share (some gains were erased and the company trades right now at $493 The strong results suggest that the company is effectively navigating the challenging economic environment and that its core advertising business remains healthy.

Meta's Q2 results were a positive sign for the company's future. The company's core advertising business remains strong, and its Reality Labs segment is making progress in narrowing its losses, however the scale of losses remains enormous and Meta still expects higher FY losses for this segment. The company continues investing heavily in AI, with the recent launch of Llama 3.1, an open source large language model. It is worth noting that Meta faces a $1.4 billion settlement due to alleged misuse of biometric data.

 

15 May 2026, 15:27

Market Wrap: Stocks and metals dip as Trump-Xi summit fails to break Iran deadlock 📉 (15.05.2026)

14 May 2026, 22:00

Daily Summary: Market euphoria shows no signs of letting up 🚀

14 May 2026, 21:02

Will OpenAI launch a legal battle against Apple❓�

14 May 2026, 17:50

US OPEN: Cisco shares surge; markets open higher ⏰

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.